The DMPK gene helps muscle cells and some other tissues work smoothly, especially when muscles need to tighten and then relax. This gene plays an important role in normal cell signaling, and a long repeated DNA variant in the DMPK gene can lead to myotonic dystrophy type 1, causing trouble relaxing muscles, weakness, and sometimes heart, eye, or hormone problems. People often hear about the DMPK gene through myotonic dystrophy, a condition that can run in families and vary widely from person to person.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the active parts of cells. Others are mainly involved in controlling when certain processes take place, where they occur, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in LearnHub.
Overview
DMPKGene function
What if the gene works
The DMPK gene helps make a protein that supports normal muscle and heart cell function. It helps cells manage signaling and maintain the structure needed for coordinated muscle movement.
Risk
What if the gene does not work
Changes in the DMPK gene can cause myotonic dystrophy type 1, leading to delayed muscle relaxation, muscle weakness, and wasting. Cataracts, heart rhythm problems, and learning or hormone related issues may also occur, with effects ranging from mild to severe.
Treatment
What does that mean for your treatment
No DMPK-specific treatment or drug choice is currently established in clinical guidelines. Care for people with pathogenic variants in the DMPK gene is symptom-based and guided by the problems a person has. The DMPK gene is an active research target, with treatments aimed at the expanded DMPK RNA (the gene message made by cells) under study, including antisense and other RNA-targeted approaches.
Conditions associated with DMPK
Gene function
What if the gene works
Each time a muscle cell contracts or resets, it depends on well-timed internal signals. The DMPK gene helps make one of the proteins that manages this timing, especially in muscle and heart cells. Knowing what the DMPK gene does in muscle cells helps explain how cells keep movement, structure, and communication running smoothly.
This gene helps make a kinase, a protein that adds small chemical tags to other proteins. These tags act like switches that help cells control everyday activity.
Its protein is especially active in skeletal, smooth, and heart muscle cells. It supports the internal signaling and cell layout that help these cells contract, relax, and stay organized.
The DMPK gene helps muscle cells manage calcium, a mineral that acts as an internal signal. Balanced calcium signals help muscles and the heart respond in a coordinated, steady way.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most harmful changes in the DMPK gene are CTG repeat expansions, and the DMPK CTG repeat expansion effect on RNA handling is the key problem. Instead of mainly changing the protein itself, the expanded repeat makes a toxic RNA signal that builds up in cells and traps splicing proteins, so many other gene messages are processed the wrong way. Smaller expansions may disrupt this process less, while larger expansions often cause stronger cellular effects and can be linked to earlier or more marked myotonic dystrophy type 1 features.
How variants are linked to conditions
A CTG repeat expansion in the DMPK gene causes myotonic dystrophy type 1, so the DMPK gene and myotonic dystrophy type 1 are directly linked. This inherited condition can affect muscle strength and muscle relaxation, and it may also involve the heart, eyes, breathing, and hormone systems. Larger repeat expansions are often associated with earlier onset, and some babies are born with a congenital form.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology across the general population. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DMPK, risk is mainly set by whether you inherited an expanded repeat change in the gene. Larger expansions often lead to earlier or more severe symptoms, and when the change is passed on by a mother, the chance of the very early form in a baby is higher.
Inheritance of DMPK variants
For myotonic dystrophy type 1, the DMPK inheritance pattern is autosomal dominant. If you carry a disease-causing variant in the DMPK gene, each child has a 50% chance of inheriting it, whether the child is a son or a daughter. A person only needs one altered copy of the DMPK gene to have this condition. In some families, the condition starts earlier or is more pronounced in the next generation, and the congenital form is most often passed on by the mother.
What does my DMPK result mean for my family?
For DMPK, family members can be affected across generations because this gene change is usually passed down in a dominant pattern. Parents, brothers, sisters, and children of someone with a disease-causing DMPK result may also carry it, even if symptoms are mild or started later. In some families, the condition appears at a younger age or is more severe in the next generation.
Genetic information
Genetic testing
How you find out about variants
DMPK genetic testing for myotonic dystrophy type 1 usually uses a blood sample, although saliva may also be used. A lab reads your DNA and measures the size of the repeated section in the DMPK gene to see whether an expanded variant is present. Results can confirm the diagnosis and help clarify whether it runs in a family.
When should I consider getting a genetic test?
Consider DMPK genetic testing if you or a close relative has signs of myotonic dystrophy type 1, such as muscle stiffness, weakness, early cataracts, or heart rhythm problems. It can also help when this condition runs in the family or when planning a pregnancy.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals varies by the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a medication more slowly or more quickly, while others are more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, do little for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medications work. It studies gene-drug patterns to help explain why the same treatment can have different effects from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. Understanding this can support more informed, individualized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the DMPK gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing. Questions about symptoms, side effects, or changes in your medicines are best discussed with your doctor.
History
The DMPK gene entered medical history through the search for the cause of myotonic dystrophy type 1, a condition doctors had recognized for many decades before the gene was identified. Families and communities once noticed patterns that seemed to pass from parent to child. In 1992, researchers linked myotonic dystrophy type 1 to a repeated DNA sequence change in the DMPK gene, a major step for inherited disease research. This discovery helped explain why the condition can appear earlier or more strongly in later generations of a family, a pattern called anticipation. It also showed that some genetic conditions are caused by repeat expansions rather than a single letter change in DNA. From these first observations, research expanded steadily, and the DMPK gene became a classic example in medical genetics.